Login to Your Account

Consortiums the Key

Grappling with Drug-Induced Liver Toxicity - Bane of Biotech

By Brian Orelli
BioWorld Insight Contributing Writer

Tuesday, December 27, 2011

Despite biopharmas' best efforts, around 40 percent of cases of drug-induced liver injury aren't discovered in preclinical studies. That stands in stark contrast to toxicity in hematological, gastrointestinal and cardiovascular systems, where only 10 percent to 20 percent of problems aren't caught in preclinical studies.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription